Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYJournal of the Endocrine Society

Exploring genetic variants in premature ovarian insufficiency: a cohort-based investigation of monogenic etiologies.

9 affiliations
  1. 1Department of Obstetrics and Gynecology, Fertility Clinic, Hôpital Universitaire de Bruxelles (H.U.B), CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.
  2. 2Department of Human Genetics, Hôpital Universitaire de Bruxelles (H.U.B), CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.
  3. 3Clinical Sciences-Research Group Reproduction and Genetics, Centre for Medical Genetics, Medical Genetics, Vrije Universiteit Brussel VUB, Universitair Ziekenhuis Brussel UZ Brussel, Brussels 1090, Belgium.
  4. 4Clinical Sciences-Research Group Reproduction and Genetics, Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel UZ Brussel, Brussels 1090, Belgium.
  5. 5Centre for Medical Genetics, Medical Genetics, Clinical Sciences-Research Group Reproduction and Genetics, Vrije Universiteit Brussel VUB, Universitair Ziekenhuis Brussel UZ Brussel, Brussels 1090, Belgium.
  6. 6Gynecology, Fundació Puigvert de Barcelona, Hospital de Sant Pau UAB, Barcelona 08025, Spain.
  7. 7Department of Gynecology, Centre Hospitalier Universitaire de Liège, Liège 4000, Belgium.
  8. 8Department of Gynecology, Hôpital Universitaire Saint-Pierre, Brussels 1000, Belgium.
  9. 9Human Genetics, Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM), Université Libre de Bruxelles (ULB), Brussels 1070, Belgium.

Abstract

Premature ovarian insufficiency (POI), affecting about 3.5% of women under 40, is marked by menstrual irregularities, amenorrhea, and heterogeneous pubertal development. Although next-generation sequencing (NGS) has expanded the list of POI-associated genes, most cases remain unexplained, and the clinical diagnostic value of gene panels is still insufficiently assessed. This study combines a cohort-based analysis with a critical methodological reassessment of NGS diagnostic yield in POI. Prospective multicenter observational cohort study (2016-2023). Three Belgian academic hospitals. One hundred sixty unrelated women with idiopathic POI and 716 female controls. Targeted NGS of 155 POI-associated genes. Variants were classified following American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines, and genes were evaluated using the latest gene-disease relationship (GDR) scoring framework. Identification of pathogenic/likely pathogenic (P/LP) variants (primary outcome). Diagnostic yield of the gene panel based on genes with strong evidence (secondary outcome). Pathogenic/likely pathogenic variants were identified in 19.3% of patients; however, only 7.5% were considered clinically relevant based on gene validity and inheritance patterns. Limiting analysis to the 40 genes with the strongest GDR evidence yielded a 4.4% diagnostic rate. Adding 10 genes supported by recent literature increased the yield to 7.5%. In patients with primary amenorrhea, the diagnostic rate reached 15.4%. These findings highlight the gap between variant burden and true diagnostic yield in POI. Targeted NGS panels provide valuable clinical insight into POI genetics but should be complemented with broader genomic approaches for comprehensive diagnosis.

Related

  1. A premature ovarian insufficiency-associated LMD-3 point mutation impairs protein stability and causes autophagic-lysosomal dysfunction in Caenorhabditis elegans
    Yile Zhai, Tiantian Wang, Meixi Gong +4
    PLOS OnePeer-reviewedCC BY 4.0Full textCell biologyGenetics & genomicsPLOSPMC
  2. Recurrent Acute Liver Failure in Children: A Systematic Review of Genetic Etiologies, Diagnostic Clues, and Liver Transplantation
    Patryk Lipiński, Piotr Socha, Irena Jankowska
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  3. From Monogenic Variants to Polygenic Risk Scores in Inherited Cardiomyopathies: Clinical Utility, Ancestry Gaps, and Future Implementation in Arab Populations
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  4. Twenty Years of Anophthalmic Surgery in a Tertiary Referral Center: Etiologies, Surgical Trends, and Clinical Findings.
    Ali Safa Balci, Husna Topcu, Merve Emul +4
    Beyoglu eye journalPeer-reviewedCC BY-NCFull textGenetics & genomicsEurope PMC
  5. Enzymatic browning in fresh-cut fruits and vegetables: a comprehensive review of biochemical etiologies, detection techniques, and control strategies.
    Ali Hassan, Khubaib Ali, Waqar Mujahid +5
    Frontiers in nutritionPeer-reviewedCC BYFull textPlant biologyEurope PMCPMC
BibTeX
@article{sassi2026exploring,
  title = {{Exploring genetic variants in premature ovarian insufficiency: a cohort-based investigation of monogenic etiologies.}},
  author = {Asma Sassi and Xavier Peyrassol and Martina Marangoni and Alexander Gheldof and Sonia Van Dooren and Beatrice Alvaro Mercadal and Axelle Pintiaux and Caroline Antoine and Marc Abramowicz and Julie Désir and Anne Delbaere},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  month = oct,
  doi = {10.1210/jendso/bvag215},
  url = {https://europepmc.org/article/MED/42953442},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Exploring genetic variants in premature ovarian insufficiency: a cohort-based investigation of monogenic etiologies.
AU  - Asma Sassi
AU  - Xavier Peyrassol
AU  - Martina Marangoni
AU  - Alexander Gheldof
AU  - Sonia Van Dooren
AU  - Beatrice Alvaro Mercadal
AU  - Axelle Pintiaux
AU  - Caroline Antoine
AU  - Marc Abramowicz
AU  - Julie Désir
AU  - Anne Delbaere
PY  - 2026
DA  - 2026/10/28
JO  - Journal of the Endocrine Society
DO  - 10.1210/jendso/bvag215
UR  - https://europepmc.org/article/MED/42953442
AB  - Premature ovarian insufficiency (POI), affecting about 3.5% of women under 40, is marked by menstrual irregularities, amenorrhea, and heterogeneous pubertal development. Although next-generation sequencing (NGS) has expanded the list of POI-associated genes, most cases remain unexplained, and the clinical diagnostic value of gene panels is still insufficiently assessed. This study combines a cohort-based analysis with a critical methodological reassessment of NGS diagnostic yield in POI. Prospective multicenter observational cohort study (2016-2023). Three Belgian academic hospitals. One hundred sixty unrelated women with idiopathic POI and 716 female controls. Targeted NGS of 155 POI-associated genes. Variants were classified following American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines, and genes were evaluated using the latest gene-disease relationship (GDR) scoring framework. Identification of pathogenic/likely pathogenic (P/LP) variants (primary outcome). Diagnostic yield of the gene panel based on genes with strong evidence (secondary outcome). Pathogenic/likely pathogenic variants were identified in 19.3% of patients; however, only 7.5% were considered clinically relevant based on gene validity and inheritance patterns. Limiting analysis to the 40 genes with the strongest GDR evidence yielded a 4.4% diagnostic rate. Adding 10 genes supported by recent literature increased the yield to 7.5%. In patients with primary amenorrhea, the diagnostic rate reached 15.4%. These findings highlight the gap between variant burden and true diagnostic yield in POI. Targeted NGS panels provide valuable clinical insight into POI genetics but should be complemented with broader genomic approaches for comprehensive diagnosis.
SN  - 2472-1972
ER  -